Trade Insight
    • Congress Trade
    • Insider Trade
    • Latest Trade
    • Congress Members
    • Corporate Insiders
More
  • TradeInsight.info LogoTradeInsight.info
      • FeaturesPricing
  • Sign InTry for Free
TradeInsight.info logo
TradeInsight.info
Formerly PelosiTrade.com
Operational
LinkedInGithubDiscord

Disclosures

  • Terms of Service
  • Privacy Policy
  • Cookie Policy
  • Product Updates

Knowledge

  • FAQ
  • Comparison guide
  • Security

Connect

  • About us
  • Contact
  • Careers

©2023-2025 TradeInsight.info. All rights reserved.

  • The content on this website is not intended as financial advice. Due diligence is required.
  • The date or time indicated here is given according to the US Eastern Time Zone.
  • The listed price is in USD and refers to the closing price on the specified trade date, before any adjustments due to stock splits or mergers, unless otherwise specified.
  • The Estimated Amount from Congress Trade is the midpoint of the trade value range from the report.
Cookie Notice

We use cookies to enhance your browsing experience.

Cookie Policy
  • 1/2
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.
Forgot your password?
Insider NameBuy/SellCompany NameTickerAmountShares Change
Jul 28, 2025Jul 30, 2025Hohl Benjamin
CFO
SellEnliven Therapeutics, Inc.ELVN$20.46$66,504-12.38%
Jul 10, 2025Jul 14, 2025Hohl Benjamin
CFO
SellEnliven Therapeutics, Inc.ELVN$22.66$22,655-4.17%
Jun 27, 2025Jul 01, 2025Hohl Benjamin
CFO
SellEnliven Therapeutics, Inc.ELVN$20.91$67,956-12.38%
Jun 13, 2025Jun 17, 2025Hohl Benjamin
CFO
SellEnliven Therapeutics, Inc.ELVN$22.55$67,655-11.54%
May 27, 2025May 29, 2025Hohl Benjamin
CFO
SellEnliven Therapeutics, Inc.ELVN$16.18$52,593-12.38%
Apr 28, 2025Apr 30, 2025Hohl Benjamin
CFO
SellEnliven Therapeutics, Inc.ELVN$18.69$60,738-12.38%
Mar 27, 2025Mar 31, 2025Hohl Benjamin
CFO
SellEnliven Therapeutics, Inc.ELVN$21.33$69,321-12.38%
Feb 27, 2025Mar 04, 2025Hohl Benjamin
CFO
SellEnliven Therapeutics, Inc.ELVN$20.41$66,327-20.00%
Feb 05, 2025Feb 08, 2025Hohl Benjamin
CFO
SellEnliven Therapeutics, Inc.ELVN$22.52$22,524-7.14%
Jan 27, 2025Jan 30, 2025Hohl Benjamin
CFO
SellEnliven Therapeutics, Inc.ELVN$21.59$70,178-20.00%
Jan 03, 2025Jan 07, 2025Hohl Benjamin
CFO
SellEnliven Therapeutics, Inc.ELVN$25.04$25,039-7.14%
Dec 27, 2024Dec 31, 2024Hohl Benjamin
CFO
SellEnliven Therapeutics, Inc.ELVN$22.23$94,474-0
Nov 27, 2024Dec 02, 2024Hohl Benjamin
CFO
SellEnliven Therapeutics, Inc.ELVN$24.89$130,688-0
Oct 28, 2024Oct 30, 2024Hohl Benjamin
CFO
SellEnliven Therapeutics, Inc.ELVN$28.56$178,485-0
Oct 18, 2024Oct 22, 2024Hohl Benjamin
CFO
SellEnliven Therapeutics, Inc.ELVN$30$24,422-0
Oct 04, 2024Oct 08, 2024Hohl Benjamin
CFO
SellEnliven Therapeutics, Inc.ELVN$27.51$316,014-0
Oct 01, 2024Oct 03, 2024Hohl Benjamin
CFO
SellEnliven Therapeutics, Inc.ELVN$27.54$14,347-0
Sep 27, 2024Oct 01, 2024Hohl Benjamin
CFO
SellEnliven Therapeutics, Inc.ELVN$24.61$153,829-0
Aug 27, 2024Aug 29, 2024Hohl Benjamin
CFO
SellEnliven Therapeutics, Inc.ELVN$22.54$95,782-0
Jul 31, 2024Aug 02, 2024Hohl Benjamin
CFO
SellEnliven Therapeutics, Inc.ELVN$27.53$27,281-0
Jul 29, 2024Jul 31, 2024Hohl Benjamin
CFO
SellEnliven Therapeutics, Inc.ELVN$26.68$140,052-0
Jul 12, 2024Jul 16, 2024Hohl Benjamin
CFO
SellEnliven Therapeutics, Inc.ELVN$25.07$75,195-0
Jun 27, 2024Jul 02, 2024Hohl Benjamin
CFO
SellEnliven Therapeutics, Inc.ELVN$22.57$95,922-0
May 28, 2024May 30, 2024Hohl Benjamin
CFO
SellEnliven Therapeutics, Inc.ELVN$23.18$98,530-0
May 03, 2024May 07, 2024Hohl Benjamin
CFO
SellEnliven Therapeutics, Inc.ELVN$22.5$22,500-0
Apr 29, 2024May 01, 2024Hohl Benjamin
CFO
SellEnliven Therapeutics, Inc.ELVN$16.97$55,165-0
Apr 11, 2024Apr 15, 2024Hohl Benjamin
CFO
SellEnliven Therapeutics, Inc.ELVN$24.72$346,149-0
Mar 27, 2024Mar 29, 2024Hohl Benjamin
CFO
SellEnliven Therapeutics, Inc.ELVN$18.25$59,302-0
Feb 27, 2024Feb 29, 2024Hohl Benjamin
CFO
SellEnliven Therapeutics, Inc.ELVN$16.97$55,163-0
Jan 29, 2024Feb 01, 2024Hohl Benjamin
CFO
SellEnliven Therapeutics, Inc.ELVN$15.81$51,388-0